#pd-1

1 article with this tag

Sort by:

Immuno-Oncology CEO Time Management Across Combination Therapy Programs

How immuno-oncology CEOs manage time across PD-1, CAR-T, and bispecific combination programs while sustaining pharma partnerships and AMC relationships.

April 11, 2026 Pharmaceutical & Biotech